Literature DB >> 25721516

Methodological remarks concerning the recent meta-analysis on the effect of intravitral bevacizumab in central serous chorioretinopathy.

T N Sergentanis1, I P Chatziralli2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25721516      PMCID: PMC4506356          DOI: 10.1038/eye.2015.8

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  1 in total

Review 1.  Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review.

Authors:  Y-R Chung; E J Seo; H M Lew; K H Lee
Journal:  Eye (Lond)       Date:  2013-11-08       Impact factor: 3.775

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.